Ceftobiprole for MRSA #antibiotics

preview_player
Показать описание
A phase 3 trial shows comparable success rates between ceftobiprole and daptomycin in treating Staphylococcus aureus bacteremia. Ceftobiprole could be a viable alternative treatment, despite slightly higher adverse effects.

Join this channel to get access to perks:
Рекомендации по теме